MedTrace Logo

Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid Tumor

NCT01511146 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2012-01-19

No results posted yet for this study

Summary

The purpose of this study is to see if treatment with intrahepatic chemotherapy is a good options in patients with liver metastases. If the patients have colorectal cancer and never had got chemotherapy the investigators will use oxaliplatin together with capecitabine. If the patient is K-RAS wild type the investigators will add cetuximab. In patients who had received oxaliplatin or in patients with other cancers the investigators will use mitomycin and gemcitabine together with capecitabine.

Conditions

  • Liver Metastasis

Interventions

DRUG

Oxaliplatin

oxaliplatin 85 mg/m2 in 10 minutes

DRUG

Mitomycin + Gemcitabine

Mitomycin 5 mg/m2 Gemcitabine 1000 mg/m2

Sponsors & Collaborators

  • Copenhagen University Hospital at Herlev

    lead OTHER

Principal Investigators

  • Finn O Larsen, M.D., Ph.D · Unaffliated

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2015-07-31
Completion
2016-07-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01511146 on ClinicalTrials.gov